StockData
Petros Pharmaceuticals, Inc. logo

Petros Pharmaceuticals, Inc. (PTPI) stock

PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.00+0.00 (+5.56%)

Close on Oct 19, 2026Market cap $135.07KP/E –Yield –

Petros Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Petros Pharmaceuticals's price to sales ratio was 0.0× on Apr 30, 2025, against 1.3× a year earlier. Over the last 3 years it ranged from 0.0× to 4.1×, with a median of 1.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 20250.0×−0.3
2024Jan 31, 20240.4×−0.1
2023Dec 29, 20230.4×−0.2
2022Dec 30, 20220.6×−1.9
2021Dec 31, 20212.5×–

More Petros Pharmaceuticals figures

See a number that looks wrong?